跳至主要内容
临床试验/NCT05475873
NCT05475873已完成不适用

Ondansetron for Postspinal Anesthesia Hypotension in Patients Undergoing Cesarean Section: A Randomized, Controlled Trial

General Hospital of Ningxia Medical University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年6月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Overall stability of systolic blood pressure control versus baseline

研究概览

简要总结

The purpose of this study is to investigate the effectiveness of ondansetron for postspinal anesthesia hypotension in patients undergoing cesarean section.

详细描述

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Ondansetron have been highly demonstrated for prevention and/or treatment of post-spinal anesthesia hypotension. However, whether ondansetron could further reduction the incidence of post-spinal anesthesia hypotension is still unknown. The purpose of this study is to investigate the effectiveness of ondansetron for postspinal anesthesia hypotension in patients undergoing cesarean section.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-40 years
  • Primipara or multipara
  • Singleton pregnancy ≥ 37 weeks
  • American Society of Anesthesiologists physical status classification I to II
  • Scheduled for elective cesarean section under spinal anesthesia

排除标准

  • Body height < 150 cm
  • Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
  • Hemoglobin < 7g/dl
  • Fetal distress, or known fetal developmental anomaly

研究组 & 干预措施

Control group

Sham Comparator

A bolus of normal saline (2 ml) by IV was given 5 min before spinal anesthesia.

干预措施: normal saline (Drug)

Ondansetron 4 mg

Experimental

A bolus of ondansetron (2 ml; 4mg) by IV was given 5 min before spinal anesthesia.

干预措施: Ondansetron 4 mg (Drug)

Ondansetron 8 mg

Experimental

A bolus of ondansetron (2 ml; 8mg) by IV was given 5 min before spinal anesthesia.

干预措施: Ondansetron 8 mg (Drug)

结局指标

主要结局

Overall stability of systolic blood pressure control versus baseline

时间窗: 1-15 minutes after spinal anesthesia

Evaluated by performance error (PE)

The incidence of post-spinal anesthesia hypotension

时间窗: 1-15 minutes after spinal anesthesia

Systolic blood pressure (SBP) \< 80% of the baseline

次要结局

  • pH(Immediately after delivery)
  • APGAR score(5 min after delivery)
  • Base excess(Immediately after delivery)
  • Partial pressure of oxygen(Immediately after delivery)
  • Overall stability of heart rate control versus baseline(1-15 minutes after spinal anesthesia)
  • The incidence of nausea and vomiting.(1-15 minutes after spinal anesthesia)
  • The incidence of hypertension(1-15 minutes after spinal anesthesia)
  • The incidence of severe post-spinal anesthesia hypotension(1-15 minutes after spinal anesthesia)
  • The incidence of bradycardia.(1-15 minutes after spinal anesthesia)

研究者

发起方
General Hospital of Ningxia Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ondansetron for Postspinal Anesthesia Hypotension | 临床试验